The present and future state of hormonal treatment for male infertility

Human Reproduction Update

Volumn 9, Issue 1, 2003, Pages 9-23

  Liu, Peter Y ^a   Handelsman, David J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Aromatase; Gonadotrophin; Infertility; IVF; Male

Indexed keywords

AMITRIPTYLINE; ANDROGEN; ANTIESTROGEN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; AROMATASE INHIBITOR; CHORIONIC GONADOTROPIN; CLOMIFENE; CORTICOSTEROID; DOPAMINE RECEPTOR STIMULATING AGENT; EPHEDRINE; FOLLITROPIN; GLUCOCORTICOID; GONADORELIN DERIVATIVE; GONADOTROPIN; GONADOTROPIN DERIVATIVE; HORMONE RECEPTOR; HUMAN MENOPAUSAL GONADOTROPIN; MESTEROLONE; PLACEBO; PROLACTOSTATIN; RECOMBINANT FOLLITROPIN; SILDENAFIL; SOMATOSTATIN; STEROID; TAMOXIFEN; TESTOLACTONE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE; UNINDEXED DRUG;

ASTHENOSPERMIA; AUTOIMMUNITY; BIOCHEMISTRY; CLINICAL TRIAL; CRYPTORCHISM; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; EMPIRICISM; FEMALE; FERTILIZATION IN VITRO; FETUS MALFORMATION; FREQUENCY ANALYSIS; GENE TARGETING; GONADOTROPIN DEFICIENCY; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRACYTOPLASMIC SPERM INJECTION; LONG TERM CARE; LOW BIRTH WEIGHT; MALE; MALE FERTILITY; MALE INFERTILITY; MOLECULAR CLONING; MULTIPLE PREGNANCY; OLIGOSPERMIA; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; PROTEIN FUNCTION; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SPERM; SPERMATOGENESIS; ULTRASTRUCTURE;

ANDROGENS; DOPAMINE AGONISTS; ESTROGEN ANTAGONISTS; FEMALE; FERTILITY AGENTS, MALE; GLUCOCORTICOIDS; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; INFERTILITY, MALE; MALE; PREGNANCY;

EID: 0037223125     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/dmg002     Document Type: Review

References (194)

1. Aafjes, J.H., van der Vijver, J.C., Brugman, F.W. and Schenck, P.E. (1983) Double-blind cross over treatment with mesterolone and placebo of subfertile oligozoospermic men value of testicular biopsy. Andrologia, 15, 531-535.
2. Abel, B.J., Carswell, G., Elton, R., Hargreave, T.B., Kyle, K., Orr, S., Rogers, A., Baxby, K. and Yates, A. (1982) Randomised trial of clomiphene citrate treatment and vitamin C for male infertility. Br. J. Urol., 54, 780-784.
3. Abramov, Y., Elchalal, U. and Schenker, J.G. (1999) Severe OHSS: an 'epidemic' of severe OHSS. A price we have to pay? Hum. Reprod., 14, 2181-2183.
4. Abshagen, K., Behre, H.M., Cooper, T.G. and Nieschlag, E. (1998) Influence of sperm surface antibodies on spontaneous pregnancy rates. Fertil. Steril., 70, 355-356.
5. Acosta, A.A., Khalifa, E. and Oehninger, S. (1992) Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience. Hum. Reprod., 7, 1067-1072.
6. Adamopoulos, D.A., Nicopoulou, S., Kapolla, N., Vassilopoulos, P., Karamertzanis, M. and Kontogeorgos, L. (1995) Endocrine effects of testosterone undecanoate as a supplementary treatment to menopausal gonadotropins or tamoxifen citrate in idiopathic oligozoospermia. Fertil. Steril., 64, 818-824.
7. Adamopoulos, D.A., Nicopoulou, S., Kapolla, N., Karamertzanis, M. and Andreou, E. (1997) The combination of testosterone undecanoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia. Fertil. Steril., 67, 756-762.
8. AinMelk, Y., Belisle, S., Kandalaft, N., McClure, D., Tetreault, L. and Elhilali, M. (1982) Bromocriptine therapy in oligozoospermic infertile men. Arch. Androl., 8, 135-141.
9. AinMelk, Y., Belisle, S., Carmel, M. and Jean-Pierre, T. (1987) Tamoxifen citrate therapy in male infertility. Fertil. Steril., 48, 113-117.
10. Akre, O., Cnattingius, S., Bergstrom, R., Kvist, U., Trichopoulos, D. and Ekbom, A. (1999) Human fertility does not decline: evidence from Sweden. Fertil. Steril., 71, 1066-1069.
11. Anguiano, A., Oates, R.D., Amos, J.A., Dean, M., Gerrard, B., Stewart, C., Maher, T.A., White, M.B. and Milunsky, A. (1992) Congenital bilateral absence of the vas deferens: a primarily genital form of cystic fibrosis. JAMA, 267, 1794-1797.
12. Anonymous (1989) Mesterolone and idiopathic male infertility: a double-blind study. World Health Organization Task Force on the Diagnosis and Treatment of Infertility. Int. J. Androl., 12, 254-264.
13. Anonymous (1992a) A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. World Health Organization. Int. J. Androl., 15, 299-307.
14. Anonymous (1992b) Evidence-based medicine. A new approach to teaching the practice of medicine. Evidence-Based Medicine Working Group. JAMA, 268, 2420-2425.
15. Anonymous (1998) Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin HP Study Group. Fertil. Steril., 70, 256-262.
16. Anonymous (2001) Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J. Clin. Endocrinol. Metab., 86, 2607-2618.
17. Ashkenazi, J., Bar-Hava, I., Farhi, J., Levy, T., Feldberg, D., Orvieto, R. and Ben-Rafael, Z. (1999) The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertil. Steril., 72, 670-673.
18. Baccetti, B., Strehler, E., Capitani, S., Collodel, G., De Santo, M., Moretti, E., Piomboni, P., Wiedeman, R. and Sterzik, K. (1997) The effect of follicle stimulating hormone therapy on human sperm structure (Notulae seminologicae 11). Hum. Reprod., 12, 1955-1968.
19. Badenoch, D.F., Waxman, J., Boorman, L., Sidhu, B., Moore, H.D., Holt, W.V. and Blandy, J.P. (1988) Administration of a gonadotropin releasing hormone analogue in oligozoospermic infertile males. Acta Endocrinol., 117, 265-267.
20. Baker, H.W.G. (2001) Male infertility. In: DeGroot, L.J. and Jameson, J.L. (eds), Endocrinology, Volume 3. W.B.Saunders, Philadelphia, pp. 2308-2328.
21. Bals-Pratsch, M., Doren, M., Karbowski, B., Schneider, H.P. and Nieschlag, E. (1992) Cyclic corticosteroid immunosuppression is unsuccessful in the treatment of sperm antibody-related male infertility: a controlled study. Hum. Reprod., 7, 99-104.
22. Barrio, R., de Luis, D., Alonso, M., Lamas, A. and Moreno, J.C. (1999) Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism. Fertil. Steril., 71, 244-248.
23. Ben-Rafael, Z., Farhi, J., Feldberg, D., Bartoov, B., Kovo, M., Eltes, F. and Ashkenazi, J. (2000) Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertil. Steril., 73, 24-30.
24. Bex, F.J., Corbin, A. and France, E. (1982) Resistance of the mouse to the antifertility effects of LHRH agonists. Life Sci., 30, 1263-1269.
25. Bhattacharya, S., Hamilton, M.P., Shaaban, M., Khalaf, Y., Seddler, M., Ghobara, T., Braude, P., Kennedy, R., Rutherford, A., Hartshorne, G. et al. (2001) Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial. Lancet, 357, 2075-2079.
26. Blumenfeld, Z., Frisch, L. and Conn, P.M. (1988a) Gonadotropin-releasing hormone (GnRH) antibodies formation in hypogonadotropic azoospermic men treated with pulsatile GnRH - diagnosis and possible alternative treatment. Fertil. Steril., 50, 622-629.
27. Blumenfeld, Z., Makler, A., Frisch, L. and Brandes, J.M. (1988b) Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile gonadotropin-releasing hormone (GnRH). Gynecol. Endocrinol., 2, 151-164.
28. Bonduelle, M., Joris, H., Hofmans, K., Liebaers, I. and Van Steirteghem, A. (1998) Mental development of 201 ICSI children at 2 years of age. Lancet, 351, 1553.
29. Bouloux, P.M., Handelsman, D.J., Jockenhovel, F., Nieschlag, E., Rabinovici, J., Frasa, W.L., de Bie, J.J., Voortman, G. and Itskovitz-Eldor, J. (2001) First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Hum. Reprod., 16, 1592-1597.
30. Bouvattier, C., Tauber, M., Jouret, B., Chaussain, J.L. and Rochiccioli, P. (1999) Gonadotropin treatment of hypogonadotropic hypogonadal adolescents. J. Pediatr. Endocrinol. Metab., 12 (Suppl. 1), 339-344.
31. Bowen, J.R., Gibson, F.L., Leslie, G.I. and Saunders, D.M. (1998) Medical and developmental outcome at 1 year for children conceived by intracytoplasmic sperm injection. Lancet, 351, 1529-1534.
32. Brennemann, W., Brensing, K.A., Leipner, N., Boldt, I. and Klingmuller, D. (1994) Attempted protection of spermatogenesis from irradiation in patients with seminoma by D-Tryptophan-6 luteinizing hormone releasing hormone. Clin. Invest., 72, 838-842.
33. Brinster, R.L. and Avarbock, M.R. (1994) Germline transmission of donor haplotype following spermatogonial transplantation. Proc. Natl Acad. Sci. USA, 91, 11303-11307.
34. Brinster, R.L. and Zimmermann, J.W. (1994) Spermatogenesis following male germ-cell transplantation. Proc. Natl Acad. Sci. USA, 91, 11298-11302.
35. Buchter, D., Behre, H.M., Kliesch, S. and Nieschlag, E. (1998) Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur. J. Endocrinol., 139, 298-303.
36. Burger, H.G. and Baker, H.W.G. (1984) Therapeutic considerations and results of gonadotropin treatment in male hypogonadotropic hypogonadism. Ann. N. Y. Acad Sci., 438, 447-453.
37. Burgues, S. and Calderon, M.D. (1997) Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Hum. Reprod., 12, 980-986.
38. Burris, A.S., Rodbard, H.W., Winters, S.J. and Sherins, R.J. (1988) Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J. Clin. Endocrinol. Metab., 66, 1144-1151.
39. Carani, C., Granata, A.R., De Rosa, M., Garau, C., Zarrilli, S., Paesano, L., Colao, A., Marrama, P. and Lombardi, G. (1999a) The effect of chronic treatment with GH on gonadal function in men with isolated GH deficiency. Eur. J. Endocrinol., 140, 224-230.
40. Carani, C., Mantovani, R., Procopio, M., Del Rio, G., Rossetto, R. and Granata, A.R. (1999b) GH/IGF-I axis in azoospermia in primary and secondary hypogonadism: a study before and during replacement therapy. Int. J. Androl., 22, 184-189.
41. Carter, J.N., Tyson, J.E., Tolis, G., Van Vliet, S., Faiman, C. and Friesen, H.G. (1978) Prolactin-screening tumors and hypogonadism in 22 men. N. Engl. J. Med., 299, 847-852.
42. Centers for Disease Control and Prevention (2000) Society for assisted reproductive technology success rates. National summary and fertility clinic reports 1998. Volume 1. (Available at http://www.cdc.gov/nccdphp/drh/art98/PDF/art1998.pdf).
43. Chemes, H.E. (2001) Infancy is not a quiescent period of testicular development. Int. J. Androl., 24, 2-7.
44. Chilvers, C., Dudley, N.E., Gough, M.H., Jackson, M.B. and Pike, M.C. (1986) Undescended testis: the effect of treatment on subsequent risk of subfertility and malignancy. J. Pediatr. Surg., 21, 691-696.
45. Clark, R.V. and Sherins, R.J. (1989) Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover. J. Androl., 10, 240-247.
46. Clarke, G.N., Bourne, H. and Baker, H.W. (1997) Intracytoplasmic sperm injection for treating infertility associated with sperm autoimmunity. Fertil. Steril., 68, 112-117.
47. Clement, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.M. et al. (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature, 392, 398-401.
48. Cochius, J.I., Burns, R.J., Blumbergs, P.C., Mack, K. and Alderman, C.P. (1990) Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust. N. Z. J. Med., 20, 592-593.
49. Cohen, J., Garrisi, G.J., Congedo-Ferrara, T.A., Kieck, K.A., Schimmel, T.W. and Scott, R.T. (1997) Cryopreservation of single human spermatozoa. Hum. Reprod., 12, 994-1001.
50. Collins, J.A., Burrows, E.A. and Wilan, A.R. (1995) The prognosis for live birth among untreated infertile couples. Fertil. Steril., 64, 22-28.
51. Comhaire, F. (1990) Treatment of idiopathic testicular failure with high-dose testosterone undecanoate: a double-blind pilot study. Fertil. Steril., 54, 689-693.
52. Comhaire, F.H., de Kretser, D.M., Farley, T.M. and Rowe, P.J. (1987) Towards more objectivity in diagnosis and management of male fertility. Int. J. Androl., (Suppl. 7), 1-53.
53. Comhaire, F., Schoonjans, F., Abdelmassih, R., Gordts, S., Campo, R., Dhont, M., Milingos, S. and Gerris, J. (1995) Does treatment with testosterone undecanoate improve the in-vitro fertilizing capacity of spermatozoa in patients with idiopathic testicular failure? (results of a double blind study). Hum. Reprod., 10, 2600-2602.
54. Crawford, B.A., Spaliviero, J.A., Simpson, J.M. and Handelsman, D.J. (1998) Testing the gonadal regression-cytoprotection hypothesis. Cancer Res., 58, 5105-5109.
55. Crowley, W.F., Jr, Filicori, M., Spratt, D.I. and Santoro, N.F. (1985) The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog. Horm. Res., 41, 473-531.
56. da Cunha, M.F., Meistrich, M.L. and Nader, S. (1987) Absence of protection by a GnRH analogue against cyclophosphamide induced testicular cytotoxicity in the mouse. Cancer Res., 47, 1093-1097.
57. de Kretser, D.M. and Baker, H.W.G. (1999) Infertility in men: recent advances and continuing controversies. J. Clin. Endocrinol. Metab., 84, 3443-3450.
58. De Rosa, M., Colao, A., Di Sarno, A., Ferone, D., Landi, M.L., Zarrilli, S., Paesano, L., Merola, B. and Lombardi, G. (1998) Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine. Eur. J. Endocrinol., 138, 286-293.
59. de Roux, N., Young, J., Brailly-Tabard, S., Misrahi, M., Milgrom, E. and Schaison, G. (1999) The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred. J. Clin. Endocrinol. Metab., 84, 567-572.
60. Delemarre-Van de Waal, H.A. (1993) Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogonadism. Clin. Endocrinol., 38, 473-480.
61. Docimo, S.G. (1995) The results of surgical therapy for cryptorchidism: a literature review and analysis. J. Urol., 154, 1148-1152.
62. Farquhar, C.M., Prentice, A., Barlow, D.H., Evers, J.L., Vandekerckhove, P. and Vail, A. (1999) Effective treatment of subfertility: introducing the Cochrane Menstrual Disorders and Subfertility Group. Hum. Reprod., 14, 1678-1683.
63. Finkel, D.M., Phillips, J.L. and Snyder, P.J. (1985) Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N. Engl. J. Med., 313, 651-655.
64. Foresta, C., Bettella, A., Ferlin, A., Garolla, A. and Rossato, M. (1998) Evidence for a stimulatory role of follicle-stimulating hormone on the spermatogonial population in adult males. Fertil. Steril., 69, 636-642.
65. Foresta, C., Bettella, A., Merico, M., Garolla, A., Plebani, M., Ferlin, A. and Rossato, M. (2000) FSH in the treatment of oligozoospermia. Mol. Cell. Endocrinol., 161, 89-97.
66. Foresta, C., Moro, E. and Ferlin, A. (2001) Y chromosome microdeletions and alterations of spermatogenesis. Endocr. Rev., 22, 226-239.
67. Foresta, C., Bettella, A., Merico, M., Garolla, A., Ferlin, A. and Rossato, M. (2002) Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil. Steril., 77, 238-244.
68. Gerris, J., Comhaire, F., Hellemans, P., Peeters, K. and Schoonjans, F. (1991) Placebo-controlled trial of high-dose Mesterolone treatment of idiopathic male infertility. Fertil. Steril., 55, 603-607.
69. Glazener, C.M., Kelly, N.J., Weir, M.J., David, J.S., Cornes, J.S. and Hull, M.G. (1987) The diagnosis of male infertility - prospective time-specific study of conception rates related to seminal analysis and post-coital sperm-mucus penetration and survival in otherwise unexplained infertility. Hum. Reprod., 2, 665-671.
70. Glode, L.M., Robinson, J. and Gould, S.F. (1981) Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotrophin-releasing hormone. Lancet, 1, 1132-1134.
71. Gnessi, L., Fabbri, A. and Spera, G. (1997) Gonadal peptides as mediators of development and functional control of the testis: an integrated system with hormones and local environment. Endocr. Rev., 18, 541-609.
72. Gregoriou, O., Papadias, C., Gargaropoulos, A., Konidaris, S., Kontogeorgi, Z. and Kalampokas, E. (1993) Treatment of idiopathic infertility with testosterone undecanoate. A double blind study. Clin. Exp. Obstet. Gynecol., 20, 9-12.
73. Grigoriou, O., Konidaris, S., Antonaki, V., Papadias, C., Antoniou, G. and Gargaropoulos, A. (1996) Corticosteroid treatment does not improve the results of intrauterine insemination in male subfertility caused by antisperm antibodies. Eur. J. Obstet. Gynecol. Reprod. Biol., 65, 227-230.
74. Guzick, D.S., Overstreet, J.W., Factor-Litvak, P., Brazil, C.K., Nakajima, S.T., Coutifaris, C., Carson, S.A., Cisneros, P., Steinkampf, M.P., Hill, J.A. et al. (2001) Sperm morphology, motility, and concentration in fertile and infertile men. N. Engl. J. Med., 345, 1388-1393.
75. Haas, G.G., Jr and Manganiello, P. (1987) A double-blind, placebo-controlled study of the use of methylprednisolone in infertile men with sperm-associated immunoglobulins. Fertil. Steril., 47, 295-301.
76. Handelsman, D.J., Jansen, R.P.S., Boylan, L.M., Spaliviero, J.A. and Turtle, J.R. (1984) Pharmacokinetics of gonadotropin-releasing hormone: comparison of subcutaneous and intravenous routes. J. Clin. Endocrinol. Metab., 59, 739-746.
77. Hansen, M., Kurinczuk, J.J., Bower, C. and Webb, S. (2002) The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N. Engl. J. Med., 346, 725-730.
78. Hargreave, T.B., Kyle, K.F., Baxby, K., Rogers, A.C., Scott, R., Tolley, D.A., Abel, B.J., Orr, P.S. and Elton, R.A. (1984) Randomised trial of mesterolone versus vitamin C for male infertility. Scottish Infertility Group. Br. J. Urol., 56, 740-744.
79. Hargreave, T., Sweeting, V. and Elton, R. (1986) Randomised trial of tamoxifen versus vitamin C for male infertility. In: Ratman, S., Teoh, E. and Anandaukmar (eds), Advances in Fertility and Sterility Series: Infertility, Male and Female, Volume 4. Parthenon Publishing Group, pp. 51-57.
80. Hayes, F.J., Seminara, S.B., DeCruz, S., Boepple, P.A. and Crowley, W.F., Jr (2000) Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J. Clin. Endocrinol. Metab., 85, 3027-3035.
81. Healy, D.L. and Evans, J. (1993) Creutzfeldt-Jakob disease after pituitary gonadotrophins. Br. Med. J., 307, 517-518.
82. Heidenreich, A., Altmann, P. and Engelmann, U.H. (2000) Microsurgical vasovasostomy versus microsurgical epididymal sperm aspiration/ testicular extraction of sperm combined with intracytoplasmic sperm injection. A cost-benefit analysis. Eur. Urol., 37, 609-614.
83. Heller, C.G. and Clermont, Y. (1964) Kinetics of germinal epithelium in man. Recent Prog. Horm. Res., 20, 545-575.
84. Hendry, W.F., Hughes, L., Scammell, G., Pryor, J.P. and Hargreave, T.B. (1990) Comparison of prednisolone and placebo in subfertile men with antibodies to spermatozoa. Lancet, 335, 85-88.
85. Hovatta, O., Koskimies, A.I., Ranta, T., Stenman, U.H. and Seppala, M. (1979) Bromocriptine treatment of oligospermia: a double blind study. Clin. Endocrinol., 11, 377-382.
86. Hull, K.L. and Harvey, S. (2000) Growth hormone: a reproductive endocrine-paracrine regulator? Rev. Reprod., 5, 175-182.
87. Hurst, T. and Lancaster, P. (2001) Assisted conception in Australia and New Zealand 1999 and 2000. Australian Institute of Health and Welfare National Perinatal Statistics Unit, Sydney.
88. Johnson, D.H., Linde, R., Hainsworth, J.D., Vale, W., Rivier, J., Stein, R., Flexner, J., van Welch, R. and Greco, F.A. (1985) Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on post-therapy fertility in male patients with lymphoma: preliminary observations. Blood, 65, 832-836.
89. Jones, T.H. and Darne, J.F. (1993) Self-administered subcutaneous human menopausal gonadotrophin for stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotropic hypogonadism. Clin. Endocrinol., 38, 203-208.
90. Kamischke, A. and Nieschlag, E. (1999) Analysis of medical treatment of male infertility. Hum. Reprod., 14, 1-23.
91. Kamischke, A., Behre, H.M., Bergmann, M., Simoni, M., Schafer, T. and Nieschlag, E. (1998) Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum. Reprod., 13, 596-603.
92. Kandeel, F.R., Koussa, V.K. and Swerdloff, R.S. (2001) Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr. Rev., 22, 342-388.
93. Kelleher, S., Wishart, S.M., Liu, P.Y., Turner, L., Di Pierro, I., Conway, A.J. and Handelsman, D.J. (2001) Long-term outcomes of elective human sperm cryostorage. Hum. Reprod., 16, 2632-2639.
94. Khorram, O., Patrizio, P., Wang, C. and Swerdloff, R. (2001) Reproductive technologies for male infertility. J. Clin. Endocrinol. Metab., 86, 2373-2379.
95. Khosla, S., Melton, L.J., III and Riggs, B.L. (2002) Estrogen and the male skeleton. J. Clin. Endocrinol. Metab., 87, 1443-1450.
96. Kim, E.D., Winkel, E., Orejuela, F. and Lipshultz, L.I. (1998) Pathological epididymal obstruction unrelated to vasectomy: results with microsurgical reconstruction. J. Urol., 160, 2078-2080.
97. Kirk, J.M.W., Savage, M.O., Grant, D.B., Bouloux, P.M.G. and Besser, G.M. (1994) Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism. Clin. Endocrinol., 41, 57-63.
98. Kliesch, S., Behre, H.M. and Nieschlag, E. (1994) High efficacy of gonadotrophin or pulsatile gonadotrophin-releasing hormone treatment in hypogonadotrophic hypogonadal men. Eur. J. Endocrinol., 131, 347-354.
99. Klingmuller, D. and Schweikert, H.U. (1985) Maintenance of spermatogenesis by intranasal administration of gonadotropin-releasing hormone in patients with hypothalamic hypogonadism. J. Clin. Endocrinol. Metab., 61, 868-872.
100. Knuth, U.A., Honigl, W., Bals-Pratsch, M., Schleicher, G. and Nieschlag, E. (1987) Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-controlled, double blind trial. J. Clin. Endocrinol. Metab., 65, 1081-1087.
101. Krause, W., Holland-Moritz, H. and Schramm, P. (1992) Treatment of idiopathic oligozoospermia with tamoxifen - a randomized controlled study. Int. J. Androl., 15, 14-18.
102. Kreusser, E.D., Hetzel, W.D., Hautmann, R. and Pfeiffer, E.F. (1990) Reproductive toxicity with and without LHRHa administration during adjuvant chemotherapy in patients with germ cell tumors. Horm. Metab. Res., 22, 494-498.
103. Kung, A.W., Zhong, Y.Y., Lam, K.S. and Wang, C. (1994) Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism. Int. J. Androl., 17, 241-247.
104. Kupker, W., Schlegel, P.N., Al-Hasani, S., Fornara, P., Johannisson, R., Sandmann, J., Schill, T., Bals-Pratsch, M., Ludwig, M. and Diedrich, K. (2000) Use of frozen-thawed testicular sperm for intracytoplasmic sperm injection. Fertil. Steril., 73, 453-458.
105. Kurinczuk, J.J. and Bower, C. (1997) Birth defects in infants conceived by intracytoplasmic sperm injection: an alternative interpretation. Br. Med. J., 315, 1260-1265.
106. Lahteenmaki, A., Rasanen, M. and Hovatta, O. (1995) Low-dose prednisolone does not improve the outcome of in-vitro fertilization in male immunological infertility. Hum. Reprod., 10, 3124-3129.
107. Laufer, N., Yaffe, H., Margalioth, E.J., Livshin, J., Ben-David, M. and Schenker, J.G. (1981) Effect of bromocriptine treatment on male infertility associated with hyperprolactinemia. Arch. Androl., 6, 343-346.
108. Layman, L.C. (1999) Genetics of human hypogonadotropic hypogonadism. Am. J. Med. Genet., 89, 240-248.
109. Lee, K.O., Ng, S.C., Lee, P.S., Bongso, A.T., Taylor, E.A., Lin, T.K. and Ratnam, S.S. (1995a) Effect of growth hormone therapy in men with severe idiopathic oligozoospermia. Eur. J. Endocrinol., 132, 159-162.
110. Lee, P.A., O'Leary, L.A., Songer, N.J., Bellinger, M.F. and LaPorte, R.E. (1995b) Paternity after cryptorchidism: lack of correlation with age at orchidopexy. Br. J. Urol., 75, 704-707.
111. Leissner, J., Filipas, D., Wolf, H.K. and Fisch, M. (1999) The undescended testis: considerations and impact on fertility. Br. J. Urol. Int., 83, 885-891; quiz 891-892.
112. Ley, S.B. and Leonard, J.M. (1985) Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. J. Clin. Endocrinol. Metab., 61, 746-752.
113. Lindner, J., McNeil, L.W., Marney, S., Conway, M., Rivier, J., Vale, W. and Rabin, D. (1981) Characterization of human anti-luteinizing hormone-releasing hormone (LRH) antibodies in the serum of a patient with isolated gonadotropin deficiency treated with synthetic LRH. J. Clin. Endocrinol. Metab., 52, 267-270.
114. Liu, L., Banks, S.M., Banres, K.M. and Sherins, R.J. (1988) Two year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab., 67, 1140-1145.
115. Liu, P.Y., Turner, L., Rushford, D., McDonald, J., Gordon Baker, H.W., Conway, A.J. and Handelsman, D.J. (1999) Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. Hum. Reprod., 14, 1540-1545.
116. Liu, P.Y., Gebski, V.J., Turner, L., Conway, A.J., Wishart, S.M. and Handelsman, D.J. (2002a) Predicting pregnancy and spermatogenesis by survival analysis during gonadotropin treatment of gonadotropin deficient infertile men. Hum. Reprod., 17, 625-633.
117. Liu, P.Y., Wishart, S.M. and Handelsman, D.J. (2002b) A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J. Clin. Endocrinol. Metab., 87, 3125-3135.
118. Lunglmayr, G., Maier, U. and Spona, J. (1983) Therapie der idiopathischen Oligozoospermie mit Bromokriptin Resultate einer prospektiv kontrollierten Studie. Andrologia, 15 (Spec. No.), 548-553.
119. Lyon, M.F., Glenister, P.H. and Lamoreaux, M.L. (1975) Normal spermatozoa from androgen-resistant germ cells of chimaeric mice and the role of androgen in spermatogenesis. Nature, 258, 620-622.
120. Marsman, J.W. and Schats, R. (1994) The subclinical varicocele debate. Hum. Reprod., 9, 1-8.
121. Masala, A., Faedda, R., Alagna, A., Satta, A., Chiarelli, G., Rovasio, P.P., Ivaldi, R., Taras, M.S., Lai, E. and Bartoli, E. (1997) Use of testosterone to prevent cyclophosphamide-induced azoospermia. Ann. Intern. Med., 126, 292-295.
122. Mastrogiacomo, I., Motta, R.G., Botteon, S., Bonanni, G. and Schiesaro, M. (1991) Achievement of spermatogenesis and genital tract maturation in hypogonadotropic hypogonadic subjects during long term treatment with gonadotropins or LHRH. Andrologia, 23, 285-289.
123. Matorras, R., Perez, C., Corcostegui, B., Pijoan, J.I., Ramon, O., Delgado, P. and Rodriguez-Escudero, F.J. (1997) Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. Hum. Reprod., 12, 24-28.
124. Mauss, J. (1974) [Results of treatment of male fertility disorders with mesterolone or a placebo]. Arzneim.-Forsch., 24, 1338-1341.
125. Mazumdar, S. and Levine, A.S. (1998) Antisperm antibodies: etiology, pathogenesis, diagnosis, and treatment. Fertil. Steril., 70, 799-810.
126. McLachlan, R.I. (2000) The endocrine control of spermatogenesis. Best practice and research. Clin. Endocrinol. Metab., 14, 345-362.
127. Meakin, J.L., Keogh, E.J. and Martin, C.E. (1985) Human anti-luteinizing hormone-releasing hormone antibodies in patients treated with synthetic luteinizing hormone-releasing hormone. Fertil. Steril., 43, 811-813.
128. Meistrich, M.L. (1993) Effects of chemotherapy and radiotherapy on spermatogenesis. Eur. Urol., 23, 136-141; discussion 142.
129. Micic, S. and Dotlic, R. (1985) Evaluation of sperm parameters in clinical trial with clomiphene citrate of oligospermic men. J. Urol., 133, 221-222.
130. Miller, K.D., Coughlin, M.T. and Lee, P.A. (2001) Fertility after unilateral cryptorchidism. Paternity, time to conception, pretreatment testicular location and size, hormone and sperm parameters. Horm. Res., 55, 249-253.
131. Morris, I.D. (1993) Protection against cytotoxic-induced testis damage - experimental approaches. Eur. Urol., 23, 143-147.
132. Mortimer, C.H., McNeilly, A.S., Fisher, R.A., Murray, M.A. and Besser, G.M. (1974) Gonadotrophin-releasing hormone therapy in hypogonadal males with hypothalamic or pituitary dysfunction. Br. Med. J., 4, 617-621.
133. Moudgal, N.R. and Sairam, M.R. (1998) Is there a true requirement for follicle stimulating hormone in promoting spermatogenesis and fertility in primates? Hum. Reprod., 13, 916-919.
134. Nachtigall, L.B., Boepple, P.A., Pralong, F.P. and Crowley, W.F. (1997) Adult-onset idiopathic hypogonadotropic hypogonadism - a treatable form of male infertility. N. Engl. J. Med., 336, 410-415.
135. Nieschlag, E. (2000) Classification of andrological disorders. In: Nieschlag, E. and Behre, H.M. (eds), Andrology: Male Reproductive Health and Dysfunction, Volume 1. Springer: Berlin, New York.
136. Nygren, K.G. and Andersen, A.N. (2001) Assisted reproductive technology in Europe, 1997. Results generated from European registers by ESHRE. European IVF-Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum. Reprod., 16, 384-391.
137. O'Donnell, L., Robertson, K.M., Jones, M.E. and Simpson, E.R. (2001) Estrogen and spermatogenesis. Endocr. Rev., 22, 289-318.
138. O'Donovan, P.A., Vandekerckhove, P., Lilford, R.J. and Hughes, E. (1993) Treatment of male infertility: is it effective? Review and meta-analyses of published randomized controlled trials. Hum. Reprod., 8, 1209-1222.
139. Okada, Y., Kondo, T., Okamoto, S. and Ogawa, M. (1992) Induction of ovulation and spermatogenesis by hMG/hCG in hypogonadotropic GH-deficient patients. Endocrinol. Jpn., 39, 31-43.
140. Okuyama, A., Nakamura, M., Namiki, M., Aono, T., Matsumoto, K., Utsunomiya, M., Yoshioka, T., Itoh, H., Itatani, H., Mizutani, S. et al. (1986) Testicular responsiveness to long-term administration of hCG and hMG in patients with hypogonadotrophic hypogonadism. Horm. Res., 23, 21-30.
141. Ola, B., Afnan, M., Sharif, K., Papaioannou, S., Hammadieh, N. and Barratt, C.L. (2001) Should ICSI be the treatment of choice for all cases of in-vitro conception?: considerations of fertilization and embryo development, cost effectiveness and safety. Hum. Reprod., 16, 2485-2490.
142. Omu, A.E., al-Qattan, F. and Abdul Hamada, B. (1996) Effect of low dose continuous corticosteroid therapy in men with antisperm antibodies on spermatozoal quality and conception rate. Eur. J. Obstet. Gynecol. Reprod. Biol., 69, 129-134.
143. Page, D.C., Silber, S. and Brown, L.G. (1999) Men with infertility caused by AZFc deletion can produce sons by intracytoplasmic sperm injection, but are likely to transmit the deletion and infertility. Hum. Reprod., 14, 1722-1726.
144. Palermo, G., Joris, H., Devroey, P. and Van Steirteghem, A.C. (1992) Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet, 340, 17-18.
145. Palermo, G.D., Colombero, L.T., Schattman, G.L., Davis, O.K. and Rosenwaks, Z. (1996) Evolution of pregnancies and initial follow-up of newborns delivered after intracytoplasmic sperm injection. JAMA, 276, 1893-1897.
146. Palermo, G.D., Schlegel, P.N., Sills, E.S., Veeck, L.L., Zaninovic, N., Menendez, S. and Rosenwaks, Z. (1998) Births after intracytoplasmic injection of sperm obtained by testicular extraction from men with nonmosaic Klinefelter's syndrome. N. Engl. J. Med., 338, 588-590.
147. Pavlovich, C.P. and Schlegel, P.N. (1997) Fertility options after vasectomy: a cost-effectiveness analysis. Fertil. Steril., 67, 133-141.
148. Pavlovich, C.P., King, P., Goldstein, M. and Schlegel, P.N. (2001) Evidence of a treatable endocrinopathy in infertile men. J. Urol., 165, 837-841.
149. Plant, T.M. and Marshall, G.R. (2001) The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr. Rev., 22, 764-786.
150. Polansky, F.F. and Lamb, E.J. (1988) Do the results of semen analysis predict future fertility? A survival analysis study. Fertil. Steril., 49, 1059-1065.
151. Pusch, H.H. (1989) Oral treatment of oligozoospermia with testosterone-undecanoate: results of a double-blind-placebo-controlled trial. Andrologia, 21, 76-82.
152. Pyorala, S., Huttunen, N.P. and Uhari, M. (1995) A review and meta-analysis of hormonal treatment of cryptorchidism. J. Clin. Endocrinol. Metab., 80, 2795-2799.
153. Radicioni, A., Paris, E., Dondero, F., Bonifacio, V. and Isidori, A. (1994) Recombinant-growth hormone (rec-hGH) therapy in infertile men with idiopathic oligozoospermia. Acta Europaea Fertilitatis, 25, 311-317.
154. Raivio, T., Toppari, J., Perheentupa, A., McNeilly, A.S. and Dunkel, L. (1997) Treatment of prepubertal gonadotrophin-deficient boys with recombinant human follicle-stimulating hormone. Lancet, 350, 263-264.
155. Ronnberg, L. (1980) The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: a controlled double-blind cross-over study. Int. J. Androl., 3, 479-486.
156. Saal, W., Happ, J., Cordes, U., Baum, R.P. and Schmidt, M. (1991) Subcutaneous gonadotropin therapy in male patients with
157. Schieve, L.A., Meikle, S.F., Ferre, C., Peterson, H.B., Jeng, G. and Wilcox, L.S. (2002) Low and very low birth weight in infants conceived with use of assisted reproductive technology. N. Engl. J. Med., 346, 731-737.
158. Schill, W.B. and Haidl, G. (1993) Medical treatment of male infertility. In: Insler, V. and Lunenfeld, B. (eds), Infertility: Male and Female. Churchill Livingstone, Edinburgh and New York, pp. 575-622.
159. Schlatt, S., von Schonfeldt, V. and Schepers, A.G. (2000) Male germ cell transplantation: an experimental approach with a clinical perspective. Br. Med. Bull., 56, 824-836.
160. Schlegel, P.N. and Su, L.M. (1997) Physiological consequences of testicular sperm extraction. Hum. Reprod., 12, 1688-1692.
161. Schopohl, J., Mehltretter, G., von Zumbusch, R., Eversmann, T. and von Werder, K. (1991) Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism. Fertil. Steril., 56, 1143-1150.
162. Seminara, S.B., Hayes, F.J. and Crowley, W.F., Jr (1998) Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr. Rev., 19, 521-539.
163. Shalet, S.M., Beardwell, C.G., Jacobs, H.S. and Pearson, D. (1978) Testicular function following irradiation of the human prepubertal testis. Clin. Endocrinol., 9, 483-490.
164. Sherins, R.J. (1995) Are semen quality and male fertility changing? N. Engl. J. Med., 332, 327-328.
165. Shetty, G., Wilson, G., Huhtaniemi, I., Shuttlesworth, G.A., Reissmann, T. and Meistrich, M.L. (2000) Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats. Endocrinology, 141, 1735-1745.
166. Shoham, Z., Conway, G.S., Ostergaard, H., Lahlou, N., Bouchard, P. and Jacobs, H.S. (1992) Cotreatment with growth hormone for induction of spermatogenesis in patients with hypogonadotropic hypogonadism. Fertil. Steril., 57, 1044-1051.
167. Siemons, L.J. and Mahler, C.H. (1987) Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion. J. Clin. Endocrinol. Metab., 65, 585-587.
168. Snick, H.K., Snick, T.S., Evers, J.L. and Collins, J.A. (1997) The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum. Reprod., 12, 1582-1588.
169. Sokol, R.Z., Steiner, B.S., Bustillo, M., Petersen, G. and Swerdloff, R.S. (1988) A controlled comparison of the efficacy of clomiphene citrate in male infertility. Fertil. Steril., 49, 865-870.
170. Steinman, N., Gamzu, R., Yogev, L., Botchan, A., Schreiber, L. and Yavetz, H. (2001) Serum leptin concentrations are higher in azoospermic than in normozoospermic men. Fertil. Steril., 75, 821-822.
171. Sutcliffe, A.G., Taylor, B., Li, J., Thornton, S., Grudzinskas, J.G. and Lieberman, B.A. (1999) Children born after intracytoplasmic sperm injection: population control study. Br. Med. J., 318, 704-705.
172. Tachiki, H., Ito, N., Maruta, H., Kumamoto, Y. and Tsukamoto, T. (1998) Testicular findings, endocrine features and therapeutic responses of men with acquired hypogonadotropic hypogonadism. Int. J. Urol., 5, 80-85.
173. Tamashiro, K.L., Wakayama, T., Akutsu, H., Yamazaki, Y., Lachey, J.L., Wortman, M.D., Seeley, R.J., D'Alessio, D.A., Woods, S.C., Yanagimachi, R. et al. (2002) Cloned mice have an obese phenotype not transmitted to their offspring. Nature Med., 8, 262-267.
174. Tato, L., Zamboni, G., Antoniazzi, F. and Piubello, G. (1996) Gonadal function and response to growth hormone (GH) in boys with isolated GH deficiency and to GH and gonadotropins in boys with multiple pituitary hormone deficiencies. Fertil. Steril., 65, 830-834.
175. Thomson, A.B., Anderson, R.A., Irvine, D.S., Kelnar, C.J., Sharpe, R.M. and Wallace, W.H. (2002) Investigation of suppression of the hypothalamic-pituitary-gonadal axis to restore spermatogenesis in azoospermic men treated for childhood cancer. Hum. Reprod., 17, 1715-1723.
176. Torok, L. (1985) Treatment of oligozoospermia with tamoxifen (open and controlled studies). Andrologia, 17, 497-501.
177. Tournaye, H. (1997) Use of testicular sperm for the treatment of male infertility. Baillières Clin. Obstet. Gynaecol., 11, 753-762.
178. Tuerlings, J.H., Mol, B., Kremer, J.A., Looman, M., Meuleman, E.J., te Meerman, G.J., Buys, C.H., Merkus, H.M. and Scheffer, H. (1998) Mutation frequency of cystic fibrosis transmembrane regulator is not increased in oligozoospermic male candidates for intracytoplasmic sperm injection. Fertil. Steril., 69, 899-903.
179. Van Steirteghem, A.C., Nagy, Z., Joris, H., Liu, J., Staessen, C., Smitz, J., Wisanto, A. and Devroey, P. (1993) High fertilization and implantation rates after intracytoplasmic sperm injection. Hum. Reprod., 8, 1061-1066.
180. Vandekerckhove, P., O'Donovan, P.A., Lilford, R.J. and Harada, T.W. (1993) Infertility treatment: from cookery to science. The epidemiology of randomised controlled trials. Br. J. Obstet. Gynaecol., 100, 1005-1036.
181. Vandekerckhove, P., Lilford, R., Vail, A. and Hughes, E. (2001a) Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia (Cochrane Review). Cochrane Database of Systematic Reviews, Volume Issue 3. Update Software, Oxford.
182. Vandekerckhove, P., Lilford, R., Vail, A. and Hughes, E. (2001b) Bromocriptine for idiopathic oligo/asthenospermia (Cochrane Review). Volume Issue 3. Cochrane Database of Systematic Reviews. Update Software, Oxford.
183. Vandekerckhove, P., Lilford, R., Vail, A. and Hughes, E. (2001c) Clomiphene or tamoxifen for idiopathic oligo/asthenospermia (Cochrane Review). Volume Issue 3. Cochrane Database of Systematic Reviews. Update Software, Oxford.
184. Vandekerckhove, P., Lilford, R., Vail, A. and Hughes, E. (2001d) Kinin-enhancing drugs for unexplained subfertility in men (Cochrane Review). Volume Issue 3. Cochrane Database of Systematic Reviews. Update Software, Oxford.
185. Venn, A., Watson, L., Bruinsma, F., Giles, G. and Healy, D. (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet, 354, 1586-1590.
186. Vicari, E., Mongioi, A., Calogero, A.E., Moncada, M.L., Sidoti, G., Polosa, P. and D'Agata, R. (1992) Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism - long-term follow-up. Int. J. Androl., 15, 320-329.
187. Vigersky, R.A., Mozingo, D., Eil, C., Purohit, V. and Bruton, J. (1982) The antiandrogenic effects of delta 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol. Endocrinology, 110, 214-219.
188. Wang, C., Chan, C.W., Wong, K.K. and Yeung, K.K. (1983) Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia. Fertil. Steril., 40, 358-365.
189. Wang, C., Tso, S.C. and Todd, D. (1989) Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy. J. Clin. Endocrinol. Metab., 68, 511-516.
190. Waxman, J.H., Ahmed, R., Smith, D., Wrigley, P.F.M., Gregory, W., Shalet, S., Crowther, D., Rees, L.H., Besser, G.M., Malpas, J.S. et al. (1987) Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother. Pharmacol., 19, 159-162.
191. Wilmut, I. (2002) Are there any normal cloned mammals? Nature Med., 8, 215-216.
192. Zalel, Y., Draysen, E., Goldschmit, R., Zadik, Z. and Shoham, Z. (1996a) A prospective pilot study of co-treatment with growth hormone and gonadotropins for improving spermatogenesis in normogonadotropic patients with severe oligoteratoasthenospermia. Gynecol. Endocrinol., 10, 23-28.
193. Zalel, Y., Manor, M., Zadik, Z. and Shoham, Z. (1996b) Successful induction of spermatogenesis in a patient with hypogonadotropic hypogonadism following co-treatment with growth hormone. Gynecol. Endocrinol., 10, 29-31.
194. Zech, H., Vanderzwalmen, P., Prapas, Y., Lejeune, B., Duba, E. and Schoysman, R. (2000) Congenital malformations after intracytoplasmic injection of spermatids. Hum. Reprod., 15, 969-971.